Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2000
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Sep 25, 2000)
Applies certain secondary payer requirements with respect to individuals with end stage renal disease without regard to any time limitations in the case of immunosuppressive drugs furnished after this Act's enactment.
What just happenedNov 9, 2000
Referred to the Subcommittee on Health and Environment.
Who’s behind it
- Introduced in HouseSep 25, 2000
- Nov 9, 2000CommitteeH11000
Referred to the Subcommittee on Health and Environment.
Health and Environment Subcommittee - Oct 2, 2000CommitteeH11000
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 25, 2000IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Sep 25, 2000IntroReferralH11100-A
Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sep 25, 2000IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Sep 25, 2000IntroReferralB00100
Sponsor introductory remarks on measure. (CR E1581)
- Sep 25, 2000IntroReferralIntro-H
Introduced in House
- Sep 25, 2000IntroReferral1000
Introduced in House